Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 16.02
+0.43 (2.76%)
At close: Mar 6, 2026
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 7.43 billion as of March 6, 2026. Its market cap has increased by 18.02% in one year.
Market Cap
7.43B
Enterprise Value
5.72B
Revenue
950.29M
Ranking
n/a
PE Ratio
17.80
Stock Price
16.02
Market Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 7.43B, a decrease of -49.39%. That is a compound annual growth rate of -11.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.43B | 4.98% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.22B |
| Chengdu Kanghua Biological Products | 7.97B |
| Youcare Pharmaceutical Group | 7.93B |
| Anhui Huaheng Biotechnology | 7.88B |
| Suzhou Fengbei Biotech Stock | 7.83B |
| Nanjing Vazyme Biotech | 7.82B |
| Zhejiang Ausun Pharmaceutical | 7.64B |